Search results
Results from the WOW.Com Content Network
Monoamine oxidase inhibitors (MAOIs) are a class of drugs that inhibit the activity of one or both monoamine oxidase enzymes: monoamine oxidase A (MAO-A) and monoamine oxidase B (MAO-B). They are best known as effective antidepressants , especially for treatment-resistant depression and atypical depression . [ 1 ]
Side effects of rasagiline include insomnia and orthostatic hypotension, among others. [2] Rasagiline acts as an inhibitor of the enzyme monoamine oxidase (MAO) and hence is a monoamine oxidase inhibitor (MAOI). [2] More specifically, it is a selective inhibitor of monoamine oxidase B (MAO-B). [2]
In response to these adverse effects, a different type of MAOI, the class of reversible inhibitor of monoamine oxidase A (RIMA), has been developed. The primary advantage of RIMAs is that they do not require the person to follow a special diet while being purportedly effective as SSRIs and tricyclics in treating depressive disorders.
MAOIs, or monoamine oxidase inhibitors, were the first type of antidepressants developed. ... In clinical trials, the pills eased depression without the sexual side effects that can push some ...
Since some tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs) can cause harmful interactions if used within 14 days of starting treatment with other antidepressants, you may ...
Moclobemide is a benzamide, [13] derivative of morpholine, [98] which acts pharmacologically as a selective, reversible inhibitor of monoamine oxidase-A (RIMA), [10] a type of monoamine oxidase inhibitor (MAOI), and increases levels of norepinephrine (noradrenaline), dopamine, and especially serotonin [9] [99] in neuronal cells as well as in ...
Compared to older antidepressants like monoamine oxidase inhibitors (MAOIs) and tricyclic antidepressants (TCAs), SSRIs like escitalopram tend to be safer and less likely to cause side effects or ...
Side effects of pargyline include orthostatic hypotension among others. [1] It has the potential for serious food and drug interactions with sympathomimetic agents like tyramine that can result in hypertensive crisis. [1] Pargyline acts as a non-selective and irreversible inhibitor of the monoamine oxidases MAO-A and MAO-B. [6]